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The current issue of Autopsy and Case 
Reports (2013;3(1):5-14)1 has an interesting 
report by Cavalcante et al. purporting to describe 
an additional case of “hepatoid carcinoma.” 
Unfortunately, the case description does not fully 
satisfy the criteria for that diagnosis.
A number of relatively recent articles 
discuss hepatoid carcinomas.2-7 In the reported 
case, at least one of the criteria for definitive 
identification of liver tissue has not been shown: 
(a) demonstration of albumin RNA by in-situ 
hybridization or immunohistochemistry on frozen 
tissue; (b) demonstration of a canalicular pattern 
with antibody directed against polyclonal CEA; and 
(c) demonstration of bilirubin production by tumor 
cells. Further, hepatocellular carcinoma, whether 
primary in the liver or arising in an ectopic site, is 
not typically mucin-producing, and keratinization is 
quite rare. The acinar pattern shown in Figures 5 
and 6 is not seen in hepatocellular carcinoma, 
though Figure 7 certainly resembles hepatocellular 
carcinoma. Although the strong immunostaining 
for HepPar1 is suggestive, this immunostain is not 
unequivocally specific for liver cells as the authors 
note. The pattern of TTF-1 immunostaining in this 
case is also compatible with liver cells but can also 
be seen in some lung carcinomas.
This case might better be designated as a 
“pulmonary adenocarcinoma with hepatoid features” 
rather than being considered a true hepatoid 
carcinoma, unless albumin, canalicular pattern with 
pCEA, or bile production is demonstrated.
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